Cargando…
Therapeutic Potential of Emodin for Gastrointestinal Cancers
Gastrointestinal (GI) cancers cause one-third of all cancer-related deaths worldwide. Natural compounds are emerging as alternative or adjuvant cancer therapies given their distinct advantage of manipulating multiple pathways to both suppress tumor growth and alleviate cancer comorbidities; however,...
Autores principales: | McDonald, Sierra J., VanderVeen, Brandon N., Velazquez, Kandy T., Enos, Reilly T., Fairman, Ciaran M., Cardaci, Thomas D., Fan, Daping, Murphy, E. Angela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8738880/ https://www.ncbi.nlm.nih.gov/pubmed/34984952 http://dx.doi.org/10.1177/15347354211067469 |
Ejemplares similares
-
Safety of natural anthraquinone emodin: an assessment in mice
por: Sougiannis, Alexander T., et al.
Publicado: (2021) -
Emodin reduces surgical wounding‐accelerated tumor growth and metastasis via macrophage suppression in a murine triple‐negative breast cancer model
por: McDonald, Sierra J., et al.
Publicado: (2023) -
Obesity reduced survival with 5-fluorouracil and did not protect against chemotherapy-induced cachexia or immune cell cytotoxicity in mice
por: VanderVeen, Brandon N., et al.
Publicado: (2022) -
Quercetin Improved Muscle Mass and Mitochondrial Content in a Murine Model of Cancer and Chemotherapy-Induced Cachexia
por: VanderVeen, Brandon N., et al.
Publicado: (2022) -
Sub-chronic oral toxicity screening of quercetin in mice
por: Cunningham, Patrice, et al.
Publicado: (2022)